Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ i+vsp@d
%i0\1hhV<
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© -w6
"?
E;(Rm>lB
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© xi'>m IT
~,gXaw
1.Co-stimulators (or co-stimulating molecules) tiaR4PB
)@g;j>
2.NK-kB DPDe>3Mi[
uOi&G:=
3.Immunoglobulin superfamily -V<t-}h.
'
/%zi,0
4.antigen-presenting cell (APC) NeOxpn[
I=Zx"'Um
5.death domain $p* p
@ GDX7TPV
6.CCR and CXCR %Z]'!X
'3(l-nPiG^
7.Lectin (or mitogen) pxINw>
\Qv
Xa9TS"
8.Clusters of differentiation, CD) (jWss V1
j .A6S`
9.B7 family R4's7k
h5zVGr
10.Cytotoxic T lymphocyte, CTL) Wsj=!Obc
dKhA$f~
11.IL-15 and IL-15 receptor (IL-15R) !Jfs?Hy
9ptFG]lZ
12.MHC restriction H}0dd"
,d,\-x-+/
13.Affinity-chromatography S[:xqzyDg
"E=j|q
14.Cyctosprin A, CsA vR7HF*8
T6#"8qz<
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) [Gr*,nVvB
2s ,8R
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© mz7l'4']+
2h^WYpCm
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 ,Fqz e/
ZFh+x@
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ Yn51U6_S
=(r*
5vd
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ &x:JD1T}
l0]d
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© f>Td)s1
M
eo]#sf@\0
ÃâÒßѧרҵ£º %Q|eiXD
"
BTE
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ Al"3 kRJJ
E;\M1(\u
Ïû»¯ÄÚ¿Æ£º Eh8Pwt7C@
]5CNk+`'
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ;1AG3P'
i\}:hU-U
ѪҺ²¡Ñ§×¨Òµ£º |lQ;ALH!
>O`l8tM
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿